Science

Large Cancer Drug Trial Helps Move Precision Medicine Toward the Mainstream

A landmark cancer drug trial is helping set the stage for moving precision medicine into the mainstream of clinical practice, according to a new study. The study, reported in the Journal of Molecular Diagnostics, validates a procedure used in the drug trial that identifies the unique genetic mutations in a patient’s tumor, which is then used as the basis for selecting targeted drugs for treatment.

Tags: 

Pages

Subscribe to Science